OCULAR THERAPEUTIX, INC 8-K

What Happened
Ocular Therapeutix, Inc. announced its financial results for the quarter ended March 31, 2026. The company furnished a press release dated May 5, 2026, as Exhibit 99.1 to its Form 8-K to disclose those quarterly results under Item 2.02 (Results of Operations and Financial Condition).

Key Details

• Filing date: May 5, 2026 (Current Report on Form 8-K).
• Reporting period: quarter ended March 31, 2026.
• Disclosure format: press release furnished as Exhibit 99.1 (information furnished, not filed).
• Form 8-K also includes the interactive XBRL cover page (technical exhibits).

Why It Matters
This Form 8-K signals that Ocular Therapeutix has released its latest quarterly earnings and related financial details; investors should read the attached press release for the company’s reported revenue, net income (or loss), cash position, and any commentary on guidance or business trends. Because the results were furnished as an exhibit, the press release is the primary source for the specific financial metrics and management commentary investors need to evaluate the company’s near-term performance.